Fact CheckerSign in

NCT06805851Recruiting

Impact of Depression on Thermoregulation

Thermoregulatory Responses to Heat Stress in Adults With Major Depressive Disorder With and Without Antidepressant Treatment

Source: ClinicalTrials.gov · Last updated 3 Feb 2026

Brief summary (registry, in English)

The purpose of this study is to determine if, compared to non-depressed adults, differences exist in skin blood flow and sweating responses to passive heat stress in adults with clinically diagnosed depression, those with depression who are prescribed and taking SSRIs and those with depression who are prescribed and taking SNRIs.

Status (registry)
Recruiting
Study type
Observational
Enrollment
64 (estimated)
First submitted
21 Jan 2025
Start date
1 Mar 2025
Primary completion date
1 Dec 2025
Lead sponsor
Penn State University
Diseases
Depression
NCT number
NCT06805851

What you commit to

  • Study type: Observational
  • Planned participants: 64
  • From 1 Mar 2025 to the primary completion date, 1 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Plan to have surgery or relocate outside the area within the next year;
  • Medications that could alter cardiovascular or thermoregulatory responses to exercise (beta blockers, antipyretics, tricyclic antidepressants, diuretics, etc.);
  • Illegal/recreational drug use;
  • Use of psychoactive or psychopharmacological drugs other than SSRI and SNRIs within one year of participating.

Other illness

  • Allergy to latex or adhesive;
  • Any bleeding disorders, gastric ulcers, allergies to NSAIDS, asthma, kidney/liver disorders, and taking any other anticoagulants;
  • History of Crohn's disease, diverticulitis, or similar gastrointestinal disease;
  • Co-morbid psychiatric disorders (psychosis, schizophrenia, bipolar disorder, panic disorder, obsessive compulsive disorder, etc.);

Other

  • BMI \> 35
  • Are pregnant or planning to become pregnant in the next 12 months;
  • Concurrently participate in another study involving physical activity or weight loss;
  • Tobacco use;
  • Exertional chest pain or musculoskeletal pain;
  • Contraindications to a maximal exercise test or an indication for early termination of the exercise test according to the American College of Sports Medicine 10th edition Guidelines for Exercise Testing and Prescription;
  • Abnormal resting or exercise electrocardiogram (ECG);
  • Active suicidal ideation (moderate or high suicidality);

Who the study is looking for

  • Non-depressed adults aged 18-40 years;
  • OR adults aged 18-40 years with clinically diagnosed major depressive disorder according to DSM-V criteria not currently receiving antidepressant treatment;
  • OR adults aged 18-40 years with clinically diagnosed major depressive disorder with at least 2 weeks of treatment with a selective serotonin reuptake inhibitor;
  • OR aged 18-40 years adults with clinically diagnosed major depressive disorder with at least 2 weeks of treatment with a serotonin norepinephrine reuptake inhibitor;
  • All participants will be asymptomatic and no signs/symptoms of disease according to the American College of Sports Medicine 10th edition Guidelines for Exercise Testing and Prescription (chest pain or pressure, dizziness, joint pain, and signs of cardiovascular disease);
  • Systolic blood pressure 140 mmHg and diastolic pressure 90 mmHg at screening;
  • Non-diabetic
  • Not taking any other medications that might affect the physiological variables of interest (beta blockers, tricyclic antidepressants, antipyretics, diuretics, etc.);;
  • Between the 20th and 80th percentiles for sex- and age-appropriate VO2max according to the American College of Sports Medicine 10th edition Guidelines for Exercise Testing and Prescription;
  • English proficiency;
  • Capable of providing informed consent.

Age in the registry: 18 years to 40 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Noll Laboratory
Coordinator of this site? Confirm its status
University ParkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.